| Indivior Schweiz AG - Subutex 300 mg, Depot-Injektionslösung |
| 68561 | | 02 | | Subutex 300 mg | | Depot-Injektionslösung | | N07BC01 | | Buprenorphine | | 02.06.2022 | | |
|
| Composition |
| buprenorphinum 300 mg, poly(lactidum-co-glycolidum) 50/50 (0.17 - 0.22 dl/g), N-methylpyrrolidonum, ad solutionem pro 1.5 ml. |
| Packungsbestandteile |
| Depot-Injektionslösung | | | | | | Active Agent | Dose |
|---|
| Buprenorphine | 300mg / 1.5ml |
| | | | Inactive agents |
|---|
| N-Methylpyrrolidonum | | Poly(Lactidum-Co-Glycolidum) 50/50 (0.17-0.22 Dl/g) |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | PR | PR | A+ | | Yes |
|
